The smallest suffer stroke: Understanding stroke and treatment patterns in children with blunt cerebrovascular injury

Catherine C Dawson-Gore1, Emily K Myers1, Emily H Cooper2

  • 1Division of Pediatric Surgery, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.

Surgery
|April 23, 2025
PubMed

Insights

Pediatric blunt cerebrovascular injury (BCVI) treatment patterns are unclear. Young children with BCVI had higher stroke rates and received less antithrombotic therapy, necessitating treatment guidelines.

Area of Science:

  • Pediatric Traumatology
  • Vascular Neurology
  • Pediatric Critical Care

Background:

  • Blunt cerebrovascular injury (BCVI) in children is uncommon but carries significant risk.
  • Current treatment patterns and stroke rates associated with BCVI in pediatric populations are not well-defined.
  • Optimal timing and use of antithrombotic therapy for pediatric BCVI remain unknown.

Purpose of the Study:

  • To describe stroke rates and treatment patterns in children with blunt cerebrovascular injury.
  • To compare treatment strategies and outcomes across different age groups and injury severities.
  • To identify knowledge gaps regarding antithrombotic therapy in pediatric BCVI.

Main Methods:

  • Retrospective review of the Trauma Quality Improvement Program database (2016-2022).
  • Inclusion of pediatric patients (<18 years) with blunt injury and diagnosed BCVI.
  • Analysis of stroke rates and antithrombotic use, with subgroup analysis excluding traumatic brain injury and contraindications to therapy.

Main Results:

  • A total of 2,336 pediatric BCVI cases (0.34%) were identified among 685,631 blunt injuries.
  • Stroke rates were highest in the youngest children (0-6 years: 6.2%) who received antithrombotic therapy least often.
  • Patients receiving antithrombotic therapy had higher stroke rates (6.1%) compared to untreated patients (2.1%), potentially indicating delayed treatment initiation.

Conclusions:

  • Children aged 0-11 years with BCVI experienced the highest stroke rates and were least likely to receive antithrombotic therapy.
  • Over half of pediatric BCVI patients did not receive antithrombotic therapy.
  • The finding that treated patients had higher stroke rates suggests a need for standardized treatment guidelines to optimize antithrombotic use in pediatric BCVI.
Abstract

Related Concept Videos

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...